From Conformation to interaction: techniques to explore the Hsp70/hsp90 network

Proteins participate in almost every cell physiological function, and to do so, they need to reach a state that allows its function by folding and/or exposing surfaces of interactions. Spontaneous folding in the cell is in general hindered by its crowded and viscous environment, which favors misfolding and nonspecific and deleterious self-interactions. To overcome this, cells have a system, in which Hsp70 and Hsp90 play a central role to aid protein folding and avoid misfolding. The topics of this review include the biophysical tools used for monitoring protein-ligand and protein-protein interactions and also some important results related to the study of molecular chaperones and heat shock proteins (Hsp), with a focus on the Hsp70/Hsp90 network. The biophysical tools and their use to probe the conformation and interaction of Hsp70 and Hsp90 are briefly reviewed168735753CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQCOORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NÍVEL SUPERIOR - CAPESFUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPES

Human Hsp70/hsp90 Organizing Protein (hop) D456g Is A Mixture Of Monomeric And Dimeric Species.

Hop is a tetratricopeptide repeat domain (TPR)-containing co-chaperone that is able to directly associate with both Hsp70 and Hsp90. Previous data showed that the TPR2A-domain is the primary site for dimerization and that the TPR2B-domain may also play a role in dimerization. We present Hop-D456G, a mutant within the TPR2B-domain, that is a mixture of monomeric and dimeric species.17492-

Stoichiometry and thermodynamics of the interaction between the C-terminus of human 90 kDa heat shock protein Hsp90 and the mitochondrial translocase of outer membrane Tom70

A large majority of the 1000–1500 proteins in the mitochondria are encoded by the nuclear genome, and therefore, they are translated in the cytosol in the form and contain signals to enable the import of proteins into the organelle. The TOM complex is the major translocase of the outer membrane responsible for preprotein translocation. It consists of a general import pore complex and two membrane import receptors, Tom20 and Tom70. Tom70 contains a characteristic TPR domain, which is a docking site for the Hsp70 and Hsp90 chaperones. These chaperones are involved in protecting cytosolic preproteins from aggregation and then in delivering them to the TOM complex. Although highly significant, many aspects of the interaction between Tom70 and Hsp90 are still uncertain. Thus, we used biophysical tools to study the interaction between the C-terminal domain of Hsp90 (C-Hsp90), which contains the EEVD motif that binds to TPR domains, and the cytosolic fragment of Tom70. The results indicate a stoichiometry of binding of one monomer of Tom70 per dimer of C-Hsp90 with a KD of 360 ± 30 nM, and the stoichiometry and thermodynamic parameters obtained suggested that Tom70 presents a different mechanism of interaction with Hsp90 when compared with other TPR proteins investigated5132119125CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQFUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESPSem informaçãoSem informaçã

Stoichiometry And Thermodynamics Of The Interaction Between The C-terminus Of Human 90kda Heat Shock Protein Hsp90 And The Mitochondrial Translocase Of Outer Membrane Tom70.

A large majority of the 1000-1500 proteins in the mitochondria are encoded by the nuclear genome, and therefore, they are translated in the cytosol in the form and contain signals to enable the import of proteins into the organelle. The TOM complex is the major translocase of the outer membrane responsible for preprotein translocation. It consists of a general import pore complex and two membrane import receptors, Tom20 and Tom70. Tom70 contains a characteristic TPR domain, which is a docking site for the Hsp70 and Hsp90 chaperones. These chaperones are involved in protecting cytosolic preproteins from aggregation and then in delivering them to the TOM complex. Although highly significant, many aspects of the interaction between Tom70 and Hsp90 are still uncertain. Thus, we used biophysical tools to study the interaction between the C-terminal domain of Hsp90 (C-Hsp90), which contains the EEVD motif that binds to TPR domains, and the cytosolic fragment of Tom70. The results indicate a stoichiometry of binding of one monomer of Tom70 per dimer of C-Hsp90 with a K(D) of 360±30nM, and the stoichiometry and thermodynamic parameters obtained suggested that Tom70 presents a different mechanism of interaction with Hsp90 when compared with other TPR proteins investigated.513119-2

Stoichiometry and thermodynamics of the interaction between the C-terminus of human 90 kDa heat shock protein Hsp90 and the mitochondrial translocase of outer membrane Tom70

A large majority of the 1000-1500 proteins in the mitochondria are encoded by the nuclear genome, and therefore, they are translated in the cytosol in the form and contain signals to enable the import of proteins into the organelle. The TOM complex is the major translocase of the outer membrane responsible for preprotein translocation. It consists of a general import pore complex and two membrane import receptors, Tom20 and Tom70. Tom70 contains a characteristic TPR domain, which is a docking site for the Hsp70 and Hsp90 chaperones. These chaperones are involved in protecting cytosolic preproteins from aggregation and then in delivering them to the TOM complex. Although highly significant, many aspects of the interaction between Tom70 and Hsp90 are still uncertain. Thus, we used biophysical tools to study the interaction between the C-terminal domain of Hsp90 (C-Hsp90), which contains the EEVD motif that binds to TPR domains, and the cytosolic fragment of Tom70. The results indicate a stoichiometry of binding of one monomer of Tom70 per dimer of C-Hsp90 with a K(D) of 360 30 nM, and the stoichiometry and thermodynamic parameters obtained suggested that Tom70 presents a different mechanism of interaction with Hsp90 when compared with other TPR proteins investigated. (C) 2011 Elsevier Inc. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq

The Stability Of Wild-type And Deletion Mutants Of Human C-terminus Hsp70-interacting Protein (chip).

Carboxyl terminus of Hsp70 interacting protein (CHIP) is a dimeric co-chaperone involved in providing an appropriate balance between the synthesis and degradation of proteins, which is essential for normal cellular growth and function. Previous work has shown that CHIP, but not its isolated domains, has chaperone activity that is enhanced by heat. In this work, we investigate how heat and urea affect the stability of its domains. We found that the deletion mutant containing the TPR domain, which binds to chaperones Hsp70 or Hsp90, was monomeric and showed similar folding and stability to WT, while the mutant containing the U-box ubiquitin ligase domain was dimeric but had very low stability. The deletion mutants appeared to maintain most of their structure compared to the WT protein, but the regions around the tryptophan residues, which are at the interface of the domains in the WT structure, appeared to be more unfolded, which indicated that the region of contact between domains is likely important for the chaperone function.20524-

The C-terminal region of the human p23 chaperone modulates its structure and function

The p23 protein is a chaperone widely involved in protein homeostasis, well known as an Hsp90 co-chaperone since it also controls the Hsp90 chaperone cycle. Human p23 includes a β-sheet domain, responsible for interacting with Hsp90; and a charged C-terminal region whose function is not clear, but seems to be natively unfolded. p23 can undergo caspase-dependent proteolytic cleavage to form p19 (p231-142), which is involved in apoptosis, while p23 has anti-apoptotic activity. To better elucidate the function of the human p23 C-terminal region, we studied comparatively the full-length human p23 and three C-terminal truncation mutants: p231-117; p231-131 and p231-142. Our data indicate that p23 and p19 have distinct characteristics, whereas the other two truncations behave similarly, with some differences to p23 and p19. We found that part of the C-terminal region can fold in an α-helix conformation and slightly contributes to p23 thermal-stability, suggesting that the C-terminal interacts with the β-sheet domain. As a whole, our results suggest that the C-terminal region of p23 is critical for its structure-function relationship. A mechanism where the human p23 C-terminal region behaves as an activation/inhibition module for different p23 activities is proposed.The p23 protein is a chaperone widely involved in protein homeostasis, well known as an Hsp90 co-chaperone since it also controls the Hsp90 chaperone cycle. Human p23 includes a β-sheet domain, responsible for interacting with Hsp90; and a charged C-termi5655767FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULOCONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO2011/23110-0; 2012/50161-8SEM INFORMAÇÃOEchtenkamp, F.J., Freeman, B.C., (2014) The Molecular Chaperones Interaction Networks in Protein Folding and Degradation, pp. 207-232. , W.A. Houry, Springer New YorkJohnson, J.L., Toft, D.O., (1994) J. Biol. Chem., 269, pp. 24989-24993Johnson, J.L., Beito, T.G., Krco, C.J., Toft, D.O., (1994) Mol. Cell. Biol., 14, pp. 1956-1963Johnson, J.L., Toft, D.O., (1995) Mol. Endocrinol., 9, pp. 670-678Felts, S.J., Toft, D.O., (2003) Cell Stress Chaperon, 8, pp. 108-113Echtenkamp, F.J., Zelin, E., Oxelmark, E., Woo, J.I., Andrews, B.J., Garabedian, M., Freeman, B.C., (2011) Mol. Cell, 43, pp. 229-241Kobayashi, T., Nakatani, Y., Tanioka, T., Tsujimoto, M., Nakajo, S., Nakaya, K., Murakami, M., Kudo, I., (2004) Biochem. J., 381, pp. 59-69Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., Kudo, I., (2000) J. Biol. Chem., 275, pp. 32775-32782Rao, R.V., Niazi, K., Mollahan, P., Mao, X., Crippen, D., Poksay, K.S., Chen, S., Bredesen, D.E., (2006) Cell Death Differ., 13, pp. 415-425Gausdal, G., Gjertsen, B.T., Fladmark, K.E., Demol, H., Vandekerckhove, J., Doskeland, S.O., (2004) Leukemia, 18, pp. 1989-1996Mollerup, J., Berchtold, M.W., (2005) FEBS Lett., 579, pp. 4187-4192Weaver, A.J., Sullivan, W.P., Felts, S.J., Owen, B.A.L., Toft, D.O., (2000) J. Biol. Chem., 275, pp. 23045-23052Weikl, T., Abelmann, K., Buchner, J., (1999) J. Mol. Biol., 293, pp. 685-691Forafonov, F., Toogun, O.A., Grad, I., Suslova, E., Freeman, B.C., Picard, D., (2008) Mol. Cell. Biol., 28, pp. 3446-3456Martinez-Yamout, M.A., Venkitakrishnan, R.P., Preece, N.E., Kroon, G., Wright, P.E., Dyson, H.J., (2006) J. Biol. Chem., 281, pp. 14457-14464Bose, S., Weikl, T., Bugl, H., Buchner, J., (1996) Science, 274, pp. 1715-1717Freeman, B.C., Toft, D.O., Morimoto, R.I., (1996) Science, 274, pp. 1718-1720Neckers, L., (2007) J. Biosci., 32, pp. 517-530Gava, L.M., Ramos, C.H.I., (2009) Curr. Chem. Biol., 3, pp. 10-21Da Silva, V.C.H., Ramos, C.H.I., (2012) J. Proteomics, 75, pp. 2790-2802Simpson, N.E., Lambert, W.M., Watkins, R., Giashuddin, S., Huang, S.J., Oxelmark, E., Arju, R., Garabedian, M.J., (2010) Cancer Res., 70, pp. 8446-8456Young, J.C., Hartl, F.U., (2000) EMBO J., 19, pp. 5930-5940Panaretou, B., Siligardi, G., Meyer, P., Maloney, A., Sullivan, J.K., Singh, S., Millson, S.H., Prodromou, C., (2002) Mol. Cell, 10, pp. 1307-1318Richter, K., Walter, S., Buchner, J., (2004) J. Mol. Biol., 342, pp. 1403-1413Ali, M.M.U., Roe, S.M., Vaughan, C.K., Meyer, P., Panaretou, B., Piper, P.W., Prodromou, C., Pearl, L.H., (2006) Nature, 440, pp. 1013-1017Stebbins, C.E., Russo, A.A., Schneider, C., Rosen, N., Hartl, F.U., Pavletich, N.P., (1997) Cell, 89, pp. 239-250Hohfeld, J., Cyr, D.M., Patterson, C., (2001) EMBO Rep., 2, pp. 885-890Pearl, L.H., Prodromou, C., (2002) Adv. Protein Chem., 59, pp. 157-186Bohen, S.P., (1998) Mol. Biol. Cell, 18, pp. 3330-3339Grad, I., McKee, T.A., Ludwig, S.M., Hoyle, G.W., Ruiz, P., Wurst, W., Floss, T., Picard, D., (2006) Mol. Cell. Biol., 26, pp. 8976-8983Toogun, O.A., Zeiger, W., Freeman, B.C., (2007) Proc. Natl. Acad. Sci. U.S.A., 104, pp. 5765-5770Woo, S.H., An, S., Lee, H.C., Jin, H.O., Seo, S.K., Yoo, D.H., Lee, K.H., Park, I.C., (2009) J. Biol. Chem., 284, pp. 30871-30880Tosoni, K., Costa, A., Sarno, S., (2011) Mol. Cell. Biochem., 356, pp. 245-254Poksay, K., Banwait, S., Crippen, D., Mao, X., Bredesen, D., Rao, R., (2011) J. Mol. Neurosci., pp. 1-12Patwardhan, C.A., Fauq, A., Peterson, L.B., Miller, C., Blagg, B.S.J., Chadli, A., (2013) J. Biol. Chem., 288, pp. 7313-7325Deleage, G., Combet, C., Blanchet, C., Geourjon, C., (2001) Comput. Biol. Med., 31, pp. 259-267Elble, R., (1992) Biotechniques, 13, pp. 18-20Oldenburg, K.R., Vo, K.T., Michaelis, S., Paddon, C., (1997) Nucleic Acids Res., 25, pp. 451-452Kroll, E.S., Hyland, K.M., Hieter, P., Li, J.J., (1996) Genetics, 143, pp. 95-102Kushnirov, V.V., (2000) Yeast, 16, pp. 857-860Corrêa, D.H.A., Ramos, C.H.I., (2009) Afr. J. Biochem. Res., 3, pp. 164-173Schuck, P., (2000) Biophys. J., 78, pp. 1606-1619Borges, J.C., Ramos, C.H.I., (2011) Curr. Med. Chem., 18, pp. 1276-1285Konarev, P.V., Volkov, V.V., Sokolova, A.V., Koch, M.H.J., Svergun, D.I., (2003) J. Appl. Crystallogr., 36, pp. 1277-1282Semenyuk, A.V., Svergun, D.I., (1991) J. Appl. Crystallogr., 24, pp. 537-540Svergun, D.I., (1992) J. Appl. Crystallogr., 25, pp. 495-503Blom, N., Gammeltoft, S., Brunak, S., (1999) J. Mol. Biol., 294, pp. 1351-1362Olsen, J.V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., Mann, M., (2006) Cell, 127, pp. 635-648McLaughlin, S.H., Sobott, F., Yaol, Z.P., Zhang, W., Nielsen, P.R., Grossmann, J.G., Laue, E.D., Jackson, S.E., (2006) J. Mol. Biol., 356, pp. 746-758Karagoz, G.E., Duarte, A.M.S., Ippel, H., Uetrecht, C., Sinnige, T., Van Rosmalen, M., Hausmann, J., Rudiger, S.G.D., (2011) Proc. Natl. Acad. Sci. U.S.A., 108, pp. 580-585Trudeau, T., Nassar, R., Cumberworth, A., Wong, E.T., Woollard, G., Gsponer, J., (2013) Structure, 21, pp. 332-341Song, D., Li, L.S., Arsenault, P.R., Tan, Q., Bigham, A.W., Heaton-Johnson, K.J., Master, S.R., Lee, F.S., (2014) J. Biol. Chem.CHIR, JCB and LRSB are CNPq Research Fellows and thank FAPESP – Brazil (2011/23110-0; 2012/50161-8) and CNPq – Brazil for financial support. We thank the LNBio/CNPEM-ABTLuS (Campinas, Brazil) for making the AUC device available. We also thank the LNLS/CN

Structural studies of the Trypanosoma cruzi Old Yellow Enzyme: insights into enzyme dynamics and specificity

The flavoprotein old yellowenzyme of Trypanosoma cruzi (TcOYE) is an oxidoreductase that usesNAD(P)H as cofactor. This enzyme is clinically relevant due to its role in the action mechanismof some trypanocidal drugs used in the treatment of Chagas' disease by producing reactive oxygen species. In thiswork, the recombinant enzyme TcOYE was produced and collectively, X-ray crystallography, small angle X-ray scattering, analytical ultracentrifugation and molecular dynamics provided a detailed description of its structure, specificity and hydrodynamic behavior. The crystallographic structure at 1.27 Å showed a classical (α/β)8 fold with the FMN prosthetic group buried at the positively-charged active-site cleft. In solution, TcOYE behaved as a globular monomer, but it exhibited a molecular envelope larger than that observed in the crystal structure, suggesting intrinsic protein\ud flexibility. Moreover, the binding mode of β-lapachone, a trypanocidal agent, and other naphthoquinones was investigated by molecular docking and dynamics suggesting that their binding to TcOYE are stabilized mainly by interactions with the isoalloxazine ring from FMN and residues from the active-site pocket.FAPESP (07/05001-4, 11/23110-0)CNP